INS and type 2 diabetes mellitus: In the UKPDS 33 trial comparing intensive glycemic control using sulfonylurea or insulin (2729 patients) versus conventional therapy (1138 patients), the result showed no difference in incident HF in 3867 newly diagnosed T2D patients (HR, 0.91 (95% CI, 0.54–1.52)) [83].